603718 海利生物
已收盘 10-18 15:00:00
资讯
新帖
简况
海利生物大幅上涨 获主力净流入364万元
智选洞察 · 10-18 14:39
海利生物大幅上涨 获主力净流入364万元
海利生物(603718)10月16日主力资金净卖出2939.56万元
证券之星 · 10-17
海利生物(603718)10月16日主力资金净卖出2939.56万元
10月16日海利生物发布公告,其股东减持657.9万股
证券之星 · 10-16
10月16日海利生物发布公告,其股东减持657.9万股
海利生物(603718.SH)再遭知名游资章建平减持1%股份 持股降至1.06%
智通财经 · 10-16
海利生物(603718.SH)再遭知名游资章建平减持1%股份 持股降至1.06%
10月15日海利生物发布公告,其股东减持657.9万股
证券之星 · 10-15
10月15日海利生物发布公告,其股东减持657.9万股
海利生物(603718.SH)股东章建平减持公司1%股份
智通财经 · 10-15
海利生物(603718.SH)股东章建平减持公司1%股份
海利生物10月11日遭主力抛售320万元 环比增加114.77%
市场透视 · 10-11
海利生物10月11日遭主力抛售320万元 环比增加114.77%
海利生物巨额收购能否扭转业绩颓势?
电鳗快报 · 10-11
海利生物巨额收购能否扭转业绩颓势?
异动快报:海利生物(603718)10月9日14点42分触及跌停板
证券之星 · 10-09
异动快报:海利生物(603718)10月9日14点42分触及跌停板
海利生物大跌5.21% 融资余额实现4连增
智选洞察 · 10-09
海利生物大跌5.21% 融资余额实现4连增
海利生物9.35亿收购新增商誉8.1亿 标的毛利率超90%持续性存疑
长江商报 · 10-09
海利生物9.35亿收购新增商誉8.1亿 标的毛利率超90%持续性存疑
海利生物(603718.SH)股东章建平及其一致行动人累计减持公司5%股份
智通财经 · 10-08
海利生物(603718.SH)股东章建平及其一致行动人累计减持公司5%股份
10月8日海利生物发布公告,其股东减持657.54万股
证券之星 · 10-08
10月8日海利生物发布公告,其股东减持657.54万股
海利生物10月08日收涨3.09% 主力资金逆市抛售
市场透视 · 10-08
海利生物10月08日收涨3.09% 主力资金逆市抛售
海利生物创4个月新高 融资融券余额实现3连增
智选洞察 · 10-08
海利生物创4个月新高 融资融券余额实现3连增
9月30日海利生物发布公告,其股东减持657.9万股
证券之星 · 09-30
9月30日海利生物发布公告,其股东减持657.9万股
海利生物最新公告:拟9.35亿元购买瑞盛生物股权
证券之星 · 09-30
海利生物最新公告:拟9.35亿元购买瑞盛生物股权
海利生物大幅上涨 获主力净流出2227万元
智选洞察 · 09-27
海利生物大幅上涨 获主力净流出2227万元
海利生物(603718)9月26日主力资金净卖出2641.80万元
证券之星 · 09-27
海利生物(603718)9月26日主力资金净卖出2641.80万元
9月26日海利生物发布公告,其股东减持657.9万股
证券之星 · 09-26
9月26日海利生物发布公告,其股东减持657.9万股
暂无数据
公司概况
公司名称:
上海海利生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
上海海利生物技术股份有限公司主要从事动物生物制品的研发、生产和销售。公司主要产品包括兽用生物制品、医疗器械。公司是上海市农业产业化重点龙头企业,在国内兽用生物制品行业中处于领先地位。
发行价格:
6.81
{"stockData":{"symbol":"603718","market":"SH","secType":"STK","nameCN":"海利生物","latestPrice":6.33,"timestamp":1729234801000,"preClose":6.12,"halted":0,"volume":20750728,"delay":0,"floatShares":644000000,"shares":658000000,"eps":-0.0057,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"10-18 15:00:00","open":6.09,"high":6.46,"low":6.04,"amount":129000000,"amplitude":0.0686,"askPrice":6.34,"askSize":39,"bidPrice":6.33,"bidSize":1550,"shortable":0,"etf":0,"ttmEps":-0.0057,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1729474200000},"adr":0,"adjPreClose":6.12,"symbolType":"stock","openAndCloseTimeList":[[1729215000000,1729222200000],[1729227600000,1729234800000]],"highLimit":6.73,"lowLimit":5.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":657900000,"pbRate":3.32,"roa":"--","roe":"1.24%","epsLYR":0.1,"committee":0.435965,"marketValue":4165000000,"floatMarketCap":4077000000,"peRate":-1110.526297,"changeRate":0.0343,"turnoverRate":0.0322,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-10-21。"},"requestUrl":"/m/hq/s/603718/tweets","defaultTab":"tweets","newsList":[{"id":"2476478428","title":"海利生物大幅上涨 获主力净流入364万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476478428","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476478428?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:39","pubTimestamp":1729233576,"startTime":"0","endTime":"0","summary":"10月18日,海利生物股价大幅上涨,截至14点39分,海利生物上涨5.07%,报6.43元/股,成交1.15亿元,换手率2.86%。资金动向截止发稿,海利生物获得主力净流入364万元,其中超大单流入759万元,大单流出395万元。主营业务及业绩海利生物公司主营业务为畜用、禽用动物疫苗的研发、生产和销售。最新财报显示,今年中报,海利生物实现营业收入1.08亿元,同比减少9.50%,净利润为1,512.50万元,同比减少81.50%,基本每股收益为0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018151848ab6b1375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018151848ab6b1375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","603718","BK0046","BK0239"],"gpt_icon":0},{"id":"2476183299","title":"海利生物(603718)10月16日主力资金净卖出2939.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476183299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476183299?lang=zh_cn&edition=full","pubTime":"2024-10-17 08:21","pubTimestamp":1729124504,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月16日收盘,海利生物报收于6.22元,下跌2.81%,换手率2.96%,成交量19.04万手,成交额1.19亿元。近5日资金流向一览见下表:海利生物融资融券信息显示,融资方面,当日融资买入740.34万元,融资偿还890.59万元,融资净偿还150.25万元。海利生物主营业务:公司始终坚持聚焦在生物医药领域内的发展,目前主营业务分为“动保”和“人保”两个不同板块。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101700006304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603718","BK0070","BK0239"],"gpt_icon":0},{"id":"2475139359","title":"10月16日海利生物发布公告,其股东减持657.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475139359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475139359?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:00","pubTimestamp":1729087251,"startTime":"0","endTime":"0","summary":"证券之星消息,10月16日海利生物发布公告《海利生物:海利生物关于持股5%以上股东权益变动达到1%的提示性公告》,其股东章建平于2024年10月16日合计减持657.9万股,占公司目前总股本的1.0%,变动期间该股股价下跌2.81%,截止10月16日收盘报6.22元。股东增减持详情见下表:根据海利生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600036326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"gpt_icon":0},{"id":"2475994754","title":"海利生物(603718.SH)再遭知名游资章建平减持1%股份 持股降至1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475994754","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475994754?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:15","pubTimestamp":1729084526,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海利生物(603718.SH)发布公告,公司于2024年10月16日收到股东章建平发来的《关于权益变动达到1%的告知函》,获悉在2024年10月16日,章建平通过集中竞价交易方式减持公司无限售流通股657.90万股,达到公司总股本的1%。本次变动后持有股份占总股本1.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603718","BK0239","BK0070","BK0046"],"gpt_icon":0},{"id":"2475525940","title":"10月15日海利生物发布公告,其股东减持657.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475525940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475525940?lang=zh_cn&edition=full","pubTime":"2024-10-15 17:05","pubTimestamp":1728983136,"startTime":"0","endTime":"0","summary":"证券之星消息,10月15日海利生物发布公告《海利生物:海利生物关于持股5%以上股东权益变动达到1%的提示性公告》,其股东章建平于2024年10月15日合计减持657.9万股,占公司目前总股本的1.0%,变动期间该股股价下跌4.19%,截止10月15日收盘报6.4元。股东增减持详情见下表:根据海利生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500027950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"gpt_icon":0},{"id":"2475545476","title":"海利生物(603718.SH)股东章建平减持公司1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2475545476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475545476?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:43","pubTimestamp":1728978193,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海利生物(603718.SH)发布公告,公司于2024年10月15日收到作为合计持股5%以上股东章建平先生发来的《关于权益变动达到1%的告知函》,获悉在2024年10月15日,章建平先生通过集中竞价交易方式减持公司无限售流通股657.9万股,达到公司总股本的1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","603718","BK0046","BK0239"],"gpt_icon":0},{"id":"2474305989","title":"海利生物10月11日遭主力抛售320万元 环比增加114.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474305989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474305989?lang=zh_cn&edition=full","pubTime":"2024-10-11 15:19","pubTimestamp":1728631142,"startTime":"0","endTime":"0","summary":"10月11日, 海利生物股价跌3.81%,报收6.57元,成交金额1.16亿元,换手率2.70%,振幅5.42%,量比0.60。海利生物今日主力资金净流出320万元,上一交易日主力净流出149万元,今日环比增加114.77%。该股近5个交易日下跌2.95%,主力资金累计净流出1.03亿元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1.72亿元,其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410111538299f39bfbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410111538299f39bfbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","BK0046","603718"],"gpt_icon":0},{"id":"2474033505","title":"海利生物巨额收购能否扭转业绩颓势?","url":"https://stock-news.laohu8.com/highlight/detail?id=2474033505","media":"电鳗快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474033505?lang=zh_cn&edition=full","pubTime":"2024-10-11 08:43","pubTimestamp":1728607380,"startTime":"0","endTime":"0","summary":"9月30日晚间,海利生物披露重大资产购买及重大资产出售报告书(修订稿)。海利生物 并购公告海利生物发布的2024年上半年业绩报告显示,报告期内,海利生物营业收入较上年同期下降9.50%,归属于上市公司股东的净利润和归属于上市公司股东的扣除非经常性损益的净利润较上年同期分别下降81.50%和164.76%。海利生物 2024年上半年报告业内人士指出,完成收购后,企业面临的不仅仅是财务上的整合,更重要的是业务、文化、管理等多方面的深度融合。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011084555959e8e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011084555959e8e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603718","BK0070","BK0046","BK0239"],"gpt_icon":0},{"id":"2474881296","title":"异动快报:海利生物(603718)10月9日14点42分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2474881296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474881296?lang=zh_cn&edition=full","pubTime":"2024-10-09 14:48","pubTimestamp":1728456519,"startTime":"0","endTime":"0","summary":"证券之星10月9日盘中消息,14点42分海利生物(603718)触及跌停板。目前价格6.91,下跌10.03%。其所属行业动物保健目前下跌。该股为疫苗,口腔,新冠病毒防治概念热股。10月8日的资金流向数据方面,主力资金净流出4674.02万元,占总成交额14.29%,游资资金净流入1637.33万元,占总成交额5.01%,散户资金净流入3036.7万元,占总成交额9.28%。近5日资金流向一览见下表:海利生物主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900017485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"gpt_icon":0},{"id":"2474267182","title":"海利生物大跌5.21% 融资余额实现4连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2474267182","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474267182?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:31","pubTimestamp":1728437473,"startTime":"0","endTime":"0","summary":"10月09日,海利生物股价大幅下跌,截至09点31分,海利生物下跌5.21%,报7.28元/股,成交532万元,换手率0.11%。资金动向截止发稿,海利生物获得主力净流出1854万元,其中超大单流出1831万元,大单流出22万元。融资融券方面,海利生物10月08日获得融资净买入2388万元,当日该股融资余额为2.45亿元,当较前一日增加11.06%,实现4连增;该股融券余额为69万元,融券余量为9.57万股,比上日减少1.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009132844ab68ba5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009132844ab68ba5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0239","603718","BK0070"],"gpt_icon":0},{"id":"2474230572","title":"海利生物9.35亿收购新增商誉8.1亿 标的毛利率超90%持续性存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2474230572","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474230572?lang=zh_cn&edition=full","pubTime":"2024-10-09 08:03","pubTimestamp":1728432219,"startTime":"0","endTime":"0","summary":"瑞盛生物的毛利率超过90%,如此之高的毛利率持续性存疑。根据海利生物披露,公司拟出资9.35亿元收购瑞盛生物55%的股份,同时出售药明海德30%股权,交易价格约为1.09亿美元。本次交易,海利生物出资9.35亿元收购瑞盛生物55%股权,新增商誉高达8.11亿元。海利生物本次收购的瑞盛生物,主营业务为口腔组织修复与再生材料。备受关注的是,瑞盛生物的毛利率超过90%,公司预计,到2028年,其毛利率仍然维持在80%左右。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090816579f33273d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090816579f33273d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","603718","BK0070","BK0239"],"gpt_icon":0},{"id":"2473425684","title":"海利生物(603718.SH)股东章建平及其一致行动人累计减持公司5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2473425684","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473425684?lang=zh_cn&edition=full","pubTime":"2024-10-08 19:39","pubTimestamp":1728387584,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海利生物(603718.SH)发布公告,公司于2024年10月8日接到公司股东章建平、方文艳、方德基、方章乐的《简式权益变动报告书》及其他相关资料,截止2024年10月8日收盘,章建平及其一致行动人以集中竞价交易方式减持公司的股份达到3289.5万股,占公司总股本5%。本次权益变动后,方德基先生不再持有公司股份,章建平先生持有公司股份比例由4.88%变动至3.06%,章建平、方文艳、方章乐、方德基合计持有的股份比例由16.63%变动至11.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1191227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0070","603718","BK0239"],"gpt_icon":0},{"id":"2473442728","title":"10月8日海利生物发布公告,其股东减持657.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473442728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473442728?lang=zh_cn&edition=full","pubTime":"2024-10-08 18:36","pubTimestamp":1728383760,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日海利生物发布公告《海利生物:海利生物关于股东权益变动达到5%的提示性公告》,其股东章建平于2024年10月8日合计减持657.54万股,占公司目前总股本的0.9995%,变动期间该股股价上涨3.09%,截止10月8日收盘报7.68元。股东增减持详情见下表:根据海利生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800028881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","603718","BK0046","BK0239"],"gpt_icon":0},{"id":"2473165834","title":"海利生物10月08日收涨3.09% 主力资金逆市抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2473165834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473165834?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:17","pubTimestamp":1728371858,"startTime":"0","endTime":"0","summary":"10月08日, 海利生物股价涨3.09%,报收7.68元,成交金额3.27亿元,换手率6.55%,振幅12.08%,量比2.13。海利生物今日主力资金净流出5070万元,上一交易日主力净流出2823万元,今日环比增加79.60%。该股近5个交易日上涨24.88%,主力资金累计净流出1.27亿元;近20日主力资金累计净流出1.53亿元,其中净流出天数为18日。净流出前三个股分别为海利生物、生物股份、*ST贤丰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081526259597865f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081526259597865f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603718","BK0070","BK0046","BK0239"],"gpt_icon":0},{"id":"2473646215","title":"海利生物创4个月新高 融资融券余额实现3连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2473646215","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473646215?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351003,"startTime":"0","endTime":"0","summary":"10月08日,海利生物股价大幅上涨,截至09点30分,海利生物上涨8.72%,报8.10元/股,创近4个月新高,成交1174万元,换手率0.22%,振幅1.74%。资金动向截止发稿,海利生物获得主力净流出4570万元,其中超大单流出5652万元,大单流入1083万元。融资融券方面,海利生物09月30日获得融资净买入598万元,当日该股融资余额为2.21亿元,当较前一日增加2.79%,实现3连增;该股融券余额为78万元,融券余量为9.71万股,比上日减少23.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008111915ab685172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008111915ab685172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","BK0046","603718"],"gpt_icon":0},{"id":"2471877804","title":"9月30日海利生物发布公告,其股东减持657.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471877804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471877804?lang=zh_cn&edition=full","pubTime":"2024-09-30 20:14","pubTimestamp":1727698497,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日海利生物发布公告《海利生物:海利生物关于持股5%以上股东权益变动达到1%的提示性公告》,其股东方德基、章建平于2024年9月30日合计减持657.9万股,占公司目前总股本的1.0%,变动期间该股股价上涨10.04%,截止9月30日收盘报7.45元。股东增减持详情见下表:根据海利生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000039329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0070","BK0239","BK0046"],"gpt_icon":0},{"id":"2471806268","title":"海利生物最新公告:拟9.35亿元购买瑞盛生物股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2471806268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471806268?lang=zh_cn&edition=full","pubTime":"2024-09-30 19:30","pubTimestamp":1727695810,"startTime":"0","endTime":"0","summary":"海利生物公告,公司计划以现金方式购买美伦管理持有的瑞盛生物55%股权,交易价格为9.35亿元。同时,海利生物将向药明生物出售其持有的药明海德30%股权,售价为1.08亿美元。瑞盛生物主要从事口腔组织修复与再生材料的生产,属于医药制造业。药明海德则专注于人用疫苗的CRDMO业务。本次交易为重大资产重组,不构成关联交易,且两项交易相互独立,不互为前提。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000035685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0070","BK0046","BK0239"],"gpt_icon":0},{"id":"2470746391","title":"海利生物大幅上涨 获主力净流出2227万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470746391","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470746391?lang=zh_cn&edition=full","pubTime":"2024-09-27 11:21","pubTimestamp":1727407286,"startTime":"0","endTime":"0","summary":"09月27日,海利生物股价大幅上涨,截至11点21分,海利生物上涨5.59%,报6.80元/股,成交1.24亿元,换手率2.97%,振幅6.37%。资金动向截止发稿,海利生物获得主力净流出2227万元,其中超大单流出3136万元,大单流入910万元。主营业务及业绩海利生物公司主营业务为畜用、禽用动物疫苗的研发、生产和销售。最新财报显示,今年中报,海利生物实现营业收入1.08亿元,同比减少9.50%,净利润为1,512.50万元,同比减少81.50%,基本每股收益为0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927112350ab665884&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927112350ab665884&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","BK0046","603718"],"gpt_icon":0},{"id":"2470137387","title":"海利生物(603718)9月26日主力资金净卖出2641.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470137387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470137387?lang=zh_cn&edition=full","pubTime":"2024-09-27 08:23","pubTimestamp":1727396624,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月26日收盘,海利生物报收于6.44元,上涨1.1%,换手率3.48%,成交量22.43万手,成交额1.39亿元。近5日资金流向一览见下表:海利生物融资融券信息显示,融资方面,当日融资买入1006.7万元,融资偿还575.43万元,融资净买入431.27万元。海利生物主营业务:公司始终坚持聚焦在生物医药领域内的发展,目前主营业务分为“动保”和“人保”两个不同板块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700005836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"gpt_icon":0},{"id":"2470811417","title":"9月26日海利生物发布公告,其股东减持657.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470811417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470811417?lang=zh_cn&edition=full","pubTime":"2024-09-26 19:00","pubTimestamp":1727348459,"startTime":"0","endTime":"0","summary":"证券之星消息,9月26日海利生物发布公告《海利生物:海利生物关于持股5%以上股东权益变动达到1%的提示性公告》,其股东方德基于2024年9月26日合计减持657.9万股,占公司目前总股本的1.0%,变动期间该股股价上涨1.1%,截止9月26日收盘报6.44元。股东增减持详情见下表:根据海利生物2024年中报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600029310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-05-15","address":"上海市浦东新区中国(上海)自由贸易试验区临港新片区正博路1881号19幢一层1002室","stockEarnings":[{"period":"1week","weight":-0.0365},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.0515},{"period":"6month","weight":-0.1707},{"period":"1year","weight":-0.4127},{"period":"ytd","weight":-0.4061}],"companyName":"上海海利生物技术股份有限公司","boardCode":"AI0027","perCapita":"19499股","boardName":"医药制造业","registeredCapital":"65790万元","compareEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.2003},{"period":"3month","weight":0.0936},{"period":"6month","weight":0.064},{"period":"1year","weight":0.0852},{"period":"ytd","weight":0.0963}],"survey":" 上海海利生物技术股份有限公司主要从事动物生物制品的研发、生产和销售。公司主要产品包括兽用生物制品、医疗器械。公司是上海市农业产业化重点龙头企业,在国内兽用生物制品行业中处于领先地位。","serverTime":1729388850649,"listedPrice":6.81,"stockholders":"33026人(较上一季度减少3.61%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海利生物,603718,海利生物股票,海利生物股票老虎,海利生物股票老虎国际,海利生物行情,海利生物股票行情,海利生物股价,海利生物股市,海利生物股票价格,海利生物股票交易,海利生物股票购买,海利生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}